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Abstract: Prior research indicates that cost-sharing and lack of insurance coverage reduce preventive
services use among low-income persons. State Medicaid policy may affect the uptake of
recommended adult vaccinations. We examined the impact of three aspects of Medicaid benefit design
(coverage for vaccines, prohibiting cost-sharing, and copayment amounts) on vaccine uptake in the
fee-for-service Medicaid population 19–64 years old. We combined previously published reports to
obtain state Medicaid policy information from 2003 and 2012. Data on influenza vaccination uptake
were taken from the Behavioral Risk Factor Surveillance System. We used a differences-in-differences
framework, controlling for national trends and state differences, to estimate the effect of each benefit
design factor on vaccination uptake in different Medicaid-eligible populations. Each additional
dollar of copayment for vaccination decreased influenza vaccination coverage 1–6 percentage points.
The effects of covering vaccines or prohibiting cost-sharing were mixed. Imposing copayments for
vaccination is associated with lower vaccination coverage. These findings have implications for the
implementation of Medicaid expansion in states that currently impose copayments.
Keywords: vaccination; Medicaid; influenza
1. Introduction
It is well-documented that having health insurance coverage is associated with greater likelihood
of receiving recommended adult vaccines. This finding holds true across a range of adult
subpopulations and vaccine types [1–4]. Few studies examine the effect of insurance coverage for
specific preventive services, although one study using self-reported data found that insurance coverage
for vaccinations was associated with increased vaccination uptake [3]. Prior research also shows
that cost-sharing reduces use of medical care, including recommended preventive care [5], and that
the resulting reductions in usage may disproportionately affect health outcomes for low-income
individuals in poor health [6]. Studies have linked decreased out of pocket vaccination costs to
increased immunization rates particularly for disadvantaged populations [7,8]. As a result, prior to the
passage of the Affordable Care Act (ACA), several private health insurance plans waived copayments
for vaccination services [9].
The Medicaid program was established in 1965 to provide health care coverage for low-income
Americans and is one of the United States’ largest health care payers, serving close to 60 million people
each year. The program is jointly funded by federal and state governments: the federal government’s
share of every dollar spent varies by state based on the state’s per capita income, and is greater for states
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with lower per-capita incomes. States may choose to cover a variety of adults under their Medicaid
programs; however, in order to receive federal matching funds, all states must cover certain low-income
adult populations including: families with children and pregnant women [10]. These two groups are
the focus of our analysis.
While the federal government establishes certain mandatory benefits, each state administers its
own program and has considerable latitude to determine which optional benefits are covered for their
adult beneficiaries. Similarly, the federal government places restrictions on the use of cost-sharing
for certain Medicaid beneficiaries and services: for example, pregnant women are exempted from
Medicaid cost-sharing requirements for pregnancy related services. However, within federal guidelines,
state may choose whether to impose cost-sharing on other Medicaid services, such as vaccination,
and what level of cost-sharing to impose [10].
Adult immunizations are an optional benefit for traditionally-eligible Medicaid beneficiaries,
i.e., those who were eligible for Medicaid in their state prior to the passage of the ACA in 2010. In states
choosing to expand their Medicaid programs in accordance with the ACA, all vaccines recommended
by the Advisory Committee on Immunization Practices (ACIP) must be covered without cost-sharing
for all newly-eligible adult beneficiaries. Therefore, it is possible that a substantial proportion of
traditionally Medicaid eligible beneficiaries (who are the poorest and potentially most vulnerable),
even in states expanding their Medicaid programs, may not have health insurance coverage that
includes all vaccines routinely recommended for adults by ACIP.
In this paper, we examine the effect of copayment charges and other related elements
of vaccination benefit design on influenza vaccination coverage among low-income adults.
We use secondary survey data in a differences-in-differences framework to answer this question.
These findings could potentially inform state-level Medicaid benefit design policy.
2. Methods
2.1. Data
Data on vaccine coverage policy were derived from two previous analyses of Medicaid vaccine
benefit design [11,12]. These reports examined Medicaid benefit plans in 2003 and 2012 and used
document review and a survey of state Medicaid administrators to categorize elements of Medicaid
vaccine benefit design in fee-for-service Medicaid plans. Specifically, we drew from these reports
three variables related to Medicaid vaccine benefit design: (1) whether the state covered influenza
vaccines for traditionally eligible Medicaid beneficiaries; (2) whether the state prohibited cost-sharing
for vaccination services provided to adult Medicaid beneficiaries; and (3) the copayment amount
charged. Where cost sharing for immunization services was not permitted, we coded the copayment
amount as zero dollars. We limited analysis for the impacts of cost-sharing and copayment amounts to
states that covered influenza vaccine in both periods. We further restricted the copayment analysis to
states that specified copayment amounts.
Data on vaccination coverage came from the Behavioral Risk Factor Surveillance System (BRFSS).
The BRFSS is a nationally representative telephone survey of the non-institutionalized population that
asks respondents whether they have received influenza vaccines. In 2003, the BRFSS asked respondents
“During the past 12 months, have you had a flu shot?” For the 2012 BRFSS survey, the influenza vaccine
question was reworded slightly to account for the nasal spray influenza vaccine which was first
introduced in 2003. The question in 2012 read, “During the past 12 months, have you had either
a seasonal flu shot or a seasonal flu vaccine that was sprayed in your nose?” The vaccination coverage
levels presented in this analysis are based on reported vaccination in a calendar year and are not
directly comparable to published estimates of seasonal influenza vaccination from BRFSS or other
sources [13].
The BRFSS survey did not track Medicaid status, but recorded insurance status, state of
residence, household income, number of people in the household, ages of household members,
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employment status, and pregnancy status. The pregnancy query asked, “To your knowledge, are you
now pregnant?” We used these data to calculate the Federal Poverty Level for each respondent and
matched this to state-specific income eligibility limits for different Medicaid populations (namely,
in our study, pregnant women and parents) [14,15]. We limit our analysis to adults age 19 to 64,
since nearly all adults aged 65 and over are eligible for Medicare, and Medicaid is a payer of last resort.
The BRFSS does not track insurance status by source, but asks, “Do you have any kind of health care
coverage?” Our imputed Medicaid populations excluded those that responded no, but included those
that responded yes, did not know, or refused to answer the question. Therefore, our analysis population
may include adults who have private insurance coverage in addition to Medicaid. Since Medicaid
status was imputed based on other survey responses, we present results separately for all adults and
for the imputed Medicaid populations.
Pregnant women and other adults have separate eligibility thresholds for Medicaid; therefore,
we present results separately for these groups. We defined three groups of adults from the BRFSS data:
(1) all adults; (2) Medicaid enrolled pregnant women; and (3) Medicaid enrolled parents. “All adults”
included persons 19–64 years old regardless of income (i.e., Medicaid eligibility). Survey respondents
were defined as Medicaid enrolled if the midpoint of the reported household income range was below
the state limit for Medicaid eligibility for the particular qualifying category (pregnant, working parent,
or nonworking parent), they reported having health insurance coverage, and they fell into one of the
Medicaid eligibility categories included in our analysis. “Pregnant women” included female survey
respondents who reported being pregnant at the time of the survey. “Parents” included respondents
of either gender who reported there were children living in the household. While the 2012 BRFSS
questionnaire included inquiries about relationship between the respondent and other household
members, this was not asked in the 2003 survey.
Our analysis is limited to 49 states as no data were collected for the District of Columbia for 2003.
Further, as Florida only covers vaccines for institutionalized Medicaid enrollees, and the BRFSS is
limited to the non-institutionalized population, we coded Florida as not covering influenza vaccine
and omitted it from the cost-sharing and copayment analyses.
Results in Tables 1–4 are for respondents we impute to be insured with Medicaid based on
the methods described above. We have explored alternative specifications that looked at Medicaid
eligibility instead of Medicaid status and the conclusions were qualitatively unchanged. We have also
explored specifications that combine identified categories of Medicaid eligible adults (parents and
pregnant women) to increase the sample size, but again results were qualitatively unchanged.
We obtained the share of each state Medicaid population covered under fee-for-service Medicaid
from the Kaiser Family Foundation [16].
2.2. Identification Strategy
We used a differences-in-differences approach [17] to examine the impact of state Medicaid
benefits policies on vaccination coverage. Trends in states with no benefit changes were used as
controls for states with benefit changes. We used year fixed effects to control for secular trends in
vaccination coverage at the national level, and state-specific fixed effects to control for time-invariant
state-level differences in vaccine uptake and the characteristics of each state’s Medicaid population,
since the groups covered by Medicaid differ widely from state to state. Year fixed effects will
capture any variation introduced at the national level introduced by changes such as the expansion
of the populations recommended to receive influenza vaccination to include adults age 19–49 or the
introduction of the flu nasal spray as a method of immunization. We tested our model’s robustness
to this control by estimating an alternative specification of our model that includes only adults that
were universally recommended to receive influenza vaccination in both 2003 and 2012. Results were
estimated with a linear probability model that accounted for BRFSS’s complex survey sampling design
and are weighted by the fee-for-service Medicaid population. All analysis was performed with Stata
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13 (StataCorp, College Station, TX, USA) [18]. Institutional Review Board approval was not necessary
as this study comprised secondary analysis of publicly-available data.
When performing our analysis of vaccination levels, we used the state-year as the level of
analysis with population weights. We examined the effect of the dollar amount of any copayment
for immunization service, whether the state Medicaid program prohibited cost-sharing, and whether
the state Medicaid program covered the vaccine. Since our policy data were composed of two annual
snapshots, one in 2003 and one in 2012, we were unable to determine exactly when during the nine
years a state might have changed its policy. To account for this, we focused on the absolute change in
vaccination uptake between 2003 and 2012.
The benefit design aspects examined in this study pertain to fee-for-service Medicaid. In order to
account for varying levels of penetration of Medicaid managed care [19], we weighted results by the
share of the state Medicaid population in fee-for-service plans.
3. Results
Our imputed estimates of Medicaid eligible populations using the BRFSS data were 14.0 million
in 2003 (13.3 million parents and 1.0 million pregnant women) and 11.1 million in 2012 (10.6 million
parents and 0.7 million pregnant women). This decline was driven by declines in eligibility levels for
working or non-working adults in 37 states. These decreases in eligibility levels for adults were often
combined with increases in eligibility levels for children—who are excluded from this study as they
do not appear in the BRFSS and their vaccine and administration costs are covered under the Vaccines
for Children Program. The weighted mean proportion of respondents reporting influenza vaccination
increased slightly from 2003 to 2012 from 33.1% to 34.6% (p < 0.01) (Table 1). The proportion of state
Medicaid programs prohibiting cost-sharing increased from 0% to 24.6%, and the mean copayment for
Medicaid vaccination services decreased from USD$1.45 in 2003 to USD$1.22 in 2012. The proportion
of state Medicaid programs providing coverage for influenza vaccinations for adult beneficiaries
increased slightly from 2003 to 2012; however, most states already covered the vaccine in 2003.
Table 1. Mean vaccination coverage levels and benefits policy parameters for 2003 and 2012.
Parameter 2003 2012
Imputed Medicaid population: pregnant women 1.0 million 0.7 million
Imputed Medicaid population: parents 13.3 million 10.6 million
Mean influenza vaccination coverage (%) (95% CI) 33.1 (32.7, 33.5) 34.6 (34.3, 34.9)
Mean copayment for vaccination services (USD$) 1.45 1.22
% of respondents in states covering influenza vaccination (number of states) 85.4 (43) 93.7 (49)
% of respondents in states prohibiting cost sharing (number of states) 0 (0) 24.6 (20)
Notes: Influenza vaccination coverage levels are from the 2003 and 2012 Behavioral Risk Factor Surveillance System
(BRFSS). State policy attributes are from previously published reports [11,12]. Means and 95% confidence intervals
on the means are given for population level variables separately for 2003 and 2012. Copayments are measured
in nominal dollars. Each mean was significantly different across years (p < 0.01). All means are weighted by the
fee-for-service Medicaid population. The number of states (excluding District of Columbia) that allowed cost sharing
or covered the influenza vaccination is given for each year in parenthesis after the mean. The final two rows show
the percent of respondents affected by the indicated cost-sharing design with the number of states implementing
the indicated design in parentheses.
Providing Medicaid coverage benefits for influenza vaccine led to a statistically significant increase
in coverage levels for all adults (Table 2). Living in a state whose Medicaid program covered influenza
vaccine was associated with a 3.6 (p < 0.001) percentage point higher likelihood of reporting being
vaccinated. This estimate increased to 6.2 (p < 0.001) percentage points when we limited the sample to
adults age 50–64 who were universally recommended to receive the influenza vaccine in both 2003
and 2012. The point estimate of the effect of covering the influenza vaccine was similar for pregnant
women imputed to be enrolled in Medicaid (4.7 percentage points), but not statistically significant
at the 5% level (p = 0.71). The estimated impact of covering the influenza vaccine on uptake in the
Medicaid enrolled parent population was negative, but also not statistically significant.
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Table 2. Difference-in-difference impacts of covering the influenza vaccine on influenza vaccination












(N = 444,211) (N = 187,256) (N = 1335) (N = 17,255)
Impact on Influenza Vaccination 0.036 0.062 0.047 −0.000
95% CI (0.022, 0.049) (0.040, 0.085) (−0.156, 0.251) (−0.079, 0.079)
p-value <0.01 <0.01 0.65 0.99
2003 Vaccination Level (%) 28.6 41.7 15.2 19.2
Notes: Influenza vaccination coverage levels are from the 2003 and 2012 BRFSS. State policy attributes are from
previously published reports [11,12]. Each coefficient is from a separate regression for the indicated population and
policy parameter. Each regression includes controls for state of residence and year.
The impact of prohibiting cost-sharing on influenza vaccination coverage was not statistically
significant at the 5% level in each of the analytic groups (Table 3).
Table 3. Difference-in-difference impacts of prohibiting cost-sharing on influenza vaccination coverage












(N = 444,211) (N = 187,256) (N = 1335) (N = 17,255)
Impact on Influenza Vaccination 0.002 0.003 0.054 −0.029
95% CI (−0.007, 0.012) (−0.013, 0.020) (−0.123, 0.231) (−0.088, 0.031)
p-value 0.65 0.68 0.55 0.35
2003 Vaccination Level (%) 28.6 41.7 15.2 19.2
Notes: Influenza vaccination coverage levels are from the 2003 and 2012 BRFSS. State policy attributes are from
previously published reports [11,12]. Each coefficient is from a separate regression for the indicated population and
policy parameter. Each regression includes controls for state of residence and year.
In our differences-in-differences model, Medicaid copayment charges negatively impacted
influenza vaccination levels in each of the groups examined (Table 4). For all adults taken together,
a one dollar increase in Medicaid copayments charged led to a 0.6 (p = 0.014) percentage point decline
in influenza vaccination coverage. When the analysis was refined to include only adults age 50–64,
the impact was larger at −1.1 (p = 0.014) percentage points. When we estimated this effect on our
populations who were imputed to be on Medicaid, the point estimates were much larger (−6.2 for
pregnant women and −1.4 for parents), but the 95% confidence interval for both of these estimates
overlapped zero.
Table 4. Difference-in-difference impacts of copayment charges on influenza vaccination coverage for












(N = 299,344) (N = 134,459) (N = 813) (N = 10,813)
Impact on Influenza Vaccination −0.006 −0.011 −0.062 −0.014
95% CI (−0.012, −0.001) (−0.019, −0.002) (−0.145, 0.022) (−0.047, 0.018)
p-value 0.014 0.014 0.146 0.383
2003 Vaccination Level (%) 29.2 42.2 15.7 18.3
Notes: Influenza vaccination coverage levels are from the 2003 and 2012 BRFSS. State policy attributes are from
previously published reports [11,12]. Each coefficient is from a separate regression for the indicated population and
policy parameter. Each regression includes controls for state of residence and year.
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4. Discussion
Our study was one of the first to examine how vaccination coverage levels respond to financial
incentives for Medicaid beneficiaries. Our results showed benefit policies that may impose financial
barriers led to lower vaccination coverage levels among all adults. Of the three policy parameters we
analyzed, we found that providing benefits coverage for influenza vaccine had the strongest effect
on vaccination coverage. We also detected statistically significant decreases in influenza vaccine
coverage among all adults when states charged larger copays. We found that the impact of covering
the influenza vaccine on vaccine uptake was approximately equal in magnitude to (though opposite in
sign of) charging an additional USD$5 copayment.
After imputing Medicaid enrollment status, we did not find statistically significant impacts of any
of the three benefit policy variables on vaccine uptake in the enrolled subpopulations. One possible
reason we detected impacts of Medicaid policies among the general population is that our “all adults”
category included many adults who were actually eligible for Medicaid. We were unable to ascertain
if these adults would have been eligible for Medicaid through mechanisms other than family income
tests, or whose reported income was subject to measurement error.
Estimates of the impact of different vaccination benefit policies in Medicaid were highest for
Medicaid-enrolled pregnant women in all cases, although none of these estimates were statistically
significant. The larger point estimates for the Medicaid-enrolled pregnant women may indicate that
they are more sensitive to additional financial barriers. Though Medicaid prohibits cost-sharing for
pregnancy-related services; whether to permit cost-sharing for other services provided to pregnant
women, including vaccination, is at the discretion of each state program [20].
Our inability to obtain more precise statistical estimates for the population of Medicaid-enrolled
parents may be partly due to our inability to identify the legal parents in households where several adults
live with children. BRFSS interviews only one adult per household and the relationship of children in
the household to the interviewed adult was not assessed in 2003. Additionally, many of our estimates for
pregnant women and parents may not have been statistically significant due to small sample sizes.
The major limitation of this study is that our data do not provide a direct indication of Medicaid
eligibility or enrollment; instead we imputed Medicaid enrollment based on income and family size.
The Medicaid eligible population age 19–64 was 21.3 million in 2003 [21]. The total number of Medicaid
enrollees we imputed from the 2003 BRFSS was only 4.5 million, indicating imputing Medicaid
eligibility based on income and household status in the BRFSS leads to identifying only a small
fraction of eligibles. In 2009, 5% of Medicaid beneficiaries were “medically needy” [22], meaning that
their income exceeded the Medicaid eligibility ceiling in their state of residence, but their medical
expenses consumed a significant proportion of their income, rendering them eligible for Medicaid.
Other categories of low-income adults eligible for Medicaid include recipients of Supplemental Security
Income and blind or disabled persons. We were unable to identify these types of beneficiaries using the
data available. Since Medicaid eligibility is measured with error, our results are likely biased toward
zero and may underestimate the true negative impact of copayments and cost-sharing on vaccination
coverage. Similarly, we may underestimate the true positive impact of covering a vaccine in the state
Medicaid program on vaccination coverage. We were unable to obtain historical data on Medicaid
income limits for non-parents who were not pregnant. This third group is included in the “all adults”
category and may contribute to the direction of the associated point estimates. A related limitation is
that pregnancy status is measured at the time of the survey, and income limits for Medicaid eligibility
are higher (less restrictive) for pregnant women. Women imputed to be eligible for Medicaid at the
time of the survey using pregnancy income limits may have not been pregnant at the time of influenza
vaccination and thus been ineligible for Medicaid when the vaccine was received.
In addition to measurement error in Medicaid enrollment status, another limitation of this analysis
is that vaccination status in the BRFSS is self-reported. While self-reported influenza vaccination status
generally has high sensitivity (around 90%), it has a fairly low specificity around 50% [23,24]. Together,
these mean that while vaccinated individuals generally reported being vaccinated, many unvaccinated
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individuals also reported being vaccinated. We note that this additional source of measurement error
may further attenuate our estimated impacts toward zero and result in an underestimation of the
effects of Medicaid benefit design on vaccination coverage.
This study is based on the work of two previous efforts to collect information on state laws.
These efforts, funded by CDC, were quite intensive. Unfortunately, no information about changes
in cost-sharing arrangements in state Medicaid programs was collected in the time between the
two endpoints. This unfortunately places some limitations on the power of the study, as we are unable
to exploit associations in year-to-year changes in vaccine coverage and Medicaid cost-sharing design.
Further collection of this data would be merited to explore whether states are modifying cost-sharing
for grandfathered populations.
The ACA permits states to expand their Medicaid programs to include childless adults whose
incomes are 138% of the Federal Poverty Level (FPL) or lower. Prior to the ACA, eligibility limits for
this group were often well under 100% FPL. As of April 2016, 31 states and the District of Columbia
have expanded their Medicaid programs [25], and an estimated 7 million low-income adults have
become eligible for Medicaid as a result [26]. Adults who gain eligibility under Medicaid expansions,
most of which took place in 2014—two years after our data stops, will receive coverage for all
ACIP-recommended vaccines without cost sharing. Our findings suggest that providing this coverage
without cost-sharing could result in higher influenza vaccination coverage among newly-eligible
adults. A recent study indicated that few states planned to expand Medicaid benefits for traditionally
eligible enrollees to match the benefits that will be provided to new enrollees, even among states that
do not currently cover all recommended vaccines without cost-sharing [12]. Medicaid programs in
all states may wish to monitor adult vaccination uptake for both groups in their state to observe the
effects of benefit design decisions on vaccination coverage.
5. Conclusions
This study demonstrated the degree to which vaccination coverage levels are responsive to
out-of-pocket costs associated with vaccination services for Medicaid enrollees. We found that
influenza vaccination coverage is responsive to various aspects of Medicaid benefit design affecting
coverage and cost-sharing. Increased copayments may have implications for vaccine uptake and service
utilization, especially among low-income adults, and for disease transmission among the general public.
It is important for all states to monitor traditionally-eligible and—where applicable—newly-eligible
Medicaid beneficiaries in order to determine the effects of state policy decisions on uptake of
recommended vaccines.
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